AAO: Heidelberg imaging platforms poised for future of ophthalmology

Video
Conference|AAO

Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.


Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.

Information will also be available for the company’s ophthalmic image management solution platform (HEYEX 2).

Recent Videos
Professor Shahina Pardhan, BSC, PhD, MBCO, H DHealth Brad, Director of the Vision and Eye Research Institute, School of Medicine, at Anglia Ruskin University in Cambridge, United Kingdom.
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Related Content
Pencil on survey paper Image credit: ©zimmytws - adobe.stock.com

Johnson & Johnson Vision supports EC survey on potential electronic Instructions for Use expansion

Jordana Joy
September 19th 2024
Article

Depending on results from the survey for healthcare professionals, a scope expansion for eIFUs could impact ophthalmic devices including contact lenses.

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A woman with glasses looks at the camera. She has a sheet of paper in her hand. Image credit: ©KONSTANTIN SHISHKIN – stock.adobe.com

Vision loss, cholesterol identified as risk factors associated with dementia

Lynda Charters
August 5th 2024
Article

A list of 14 risk factors indicate dementia is not an inevitable consequence of aging

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A 2mg branded Ozempic injector. Image credit: ©Fernanda – stock.adobe.com

Semaglutide may be associated with non-arteritic ischemic optic neuropathy (NAION)

Lynda Charters
July 9th 2024
Article

GLP-1 receptor agonists, such as Wegovy, Ozempic and Novo Nordisk, are becoming more prolific

A black background with a red line graph going down. Image credit: ©Who is Danny – stock.adobe.com

Increase in the incidence rate of conjunctival melanoma in Australia

Lynda Charters
March 28th 2024
Article

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

© 2024 MJH Life Sciences

All rights reserved.